KR910008202B1 - 벤즈아미드 유도체의 제조방법 - Google Patents

벤즈아미드 유도체의 제조방법 Download PDF

Info

Publication number
KR910008202B1
KR910008202B1 KR1019840001083A KR840001083A KR910008202B1 KR 910008202 B1 KR910008202 B1 KR 910008202B1 KR 1019840001083 A KR1019840001083 A KR 1019840001083A KR 840001083 A KR840001083 A KR 840001083A KR 910008202 B1 KR910008202 B1 KR 910008202B1
Authority
KR
South Korea
Prior art keywords
formula
acid
compound
mol
hydrogen
Prior art date
Application number
KR1019840001083A
Other languages
English (en)
Korean (ko)
Other versions
KR840009077A (ko
Inventor
다 프라다 모제
주스 레나토
키부르츠 에밀리오
찰스 뷔스 피에르
Original Assignee
에프. 호프만-라 롯슈 에이지
페터 유레흐, 프리돌린 클라우스너
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 롯슈 에이지, 페터 유레흐, 프리돌린 클라우스너 filed Critical 에프. 호프만-라 롯슈 에이지
Publication of KR840009077A publication Critical patent/KR840009077A/ko
Application granted granted Critical
Publication of KR910008202B1 publication Critical patent/KR910008202B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019840001083A 1983-03-03 1984-03-03 벤즈아미드 유도체의 제조방법 KR910008202B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1150/83 1983-03-03
CH1150/83A CH653670A5 (de) 1983-03-03 1983-03-03 Benzamid-derivate.

Publications (2)

Publication Number Publication Date
KR840009077A KR840009077A (ko) 1984-12-24
KR910008202B1 true KR910008202B1 (ko) 1991-10-11

Family

ID=4203649

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840001083A KR910008202B1 (ko) 1983-03-03 1984-03-03 벤즈아미드 유도체의 제조방법

Country Status (28)

Country Link
JP (1) JPS59167552A (ja)
KR (1) KR910008202B1 (ja)
AR (1) AR243155A1 (ja)
AT (1) AT390948B (ja)
AU (2) AU570431B2 (ja)
BE (1) BE899059A (ja)
CA (1) CA1252794A (ja)
CH (1) CH653670A5 (ja)
DE (1) DE3407654C2 (ja)
DK (1) DK166382C (ja)
ES (3) ES530230A0 (ja)
FI (1) FI79297C (ja)
FR (1) FR2541996B1 (ja)
GB (1) GB2135998B (ja)
GR (1) GR81866B (ja)
HU (1) HU193556B (ja)
IE (1) IE57004B1 (ja)
IL (1) IL71078A (ja)
IT (1) IT1173365B (ja)
LU (1) LU85231A1 (ja)
MC (1) MC1568A1 (ja)
NL (1) NL8400459A (ja)
NO (1) NO165999C (ja)
NZ (1) NZ207272A (ja)
PH (1) PH19623A (ja)
PT (1) PT78187B (ja)
SE (1) SE466447B (ja)
ZA (1) ZA841394B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2642972B1 (fr) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342679A (en) * 1967-09-19 Parts by weight of acid chloride to react with parts of amine in
FR6557M (ja) * 1967-06-20 1968-12-23 Ile De France
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
DE2616486A1 (de) * 1976-04-14 1977-11-03 Basf Ag Farbstoffe der perylentetracarbonsaeurediimidreihe
CA1206964A (en) * 1980-11-12 1986-07-02 Nobuo Shinma Tetra-substituted benzene derivatives
DE3200258A1 (de) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
GB2135998B (en) 1986-09-24
DK147584D0 (da) 1984-02-29
FI79297C (fi) 1989-12-11
GR81866B (ja) 1984-12-12
IT8419778A0 (it) 1984-02-23
PT78187A (en) 1984-04-01
MC1568A1 (fr) 1985-02-04
NO165999B (no) 1991-02-04
JPH0430389B2 (ja) 1992-05-21
KR840009077A (ko) 1984-12-24
SE466447B (sv) 1992-02-17
AU8307987A (en) 1988-06-16
AU570431B2 (en) 1988-03-17
DK166382B (da) 1993-05-10
HU193556B (en) 1987-10-28
IL71078A0 (en) 1984-05-31
FR2541996B1 (fr) 1987-12-11
AR243155A1 (es) 1993-07-30
JPS59167552A (ja) 1984-09-21
ATA72484A (de) 1990-01-15
SE8401190L (sv) 1984-09-04
FR2541996A1 (fr) 1984-09-07
NO165999C (no) 1991-05-15
AT390948B (de) 1990-07-25
GB8405486D0 (en) 1984-04-04
AU609758B2 (en) 1991-05-09
IT1173365B (it) 1987-06-24
AU2506684A (en) 1984-09-06
NO840797L (no) 1984-09-04
PH19623A (ja) 1986-06-04
IL71078A (en) 1987-12-31
CA1252794A (en) 1989-04-18
FI840734A0 (fi) 1984-02-22
ES8504680A1 (es) 1985-05-01
ES537046A0 (es) 1985-08-16
LU85231A1 (de) 1985-09-12
ES8506600A1 (es) 1985-08-16
PT78187B (en) 1986-08-05
FI79297B (fi) 1989-08-31
ES537045A0 (es) 1985-08-16
DE3407654A1 (de) 1984-09-06
IE840512L (en) 1984-09-03
DK166382C (da) 1993-09-27
NZ207272A (en) 1987-07-31
CH653670A5 (de) 1986-01-15
FI840734A (fi) 1984-09-04
ZA841394B (en) 1985-06-26
ES8506601A1 (es) 1985-08-16
DE3407654C2 (de) 1994-04-07
IE57004B1 (en) 1992-03-11
NL8400459A (nl) 1984-10-01
ES530230A0 (es) 1985-05-01
GB2135998A (en) 1984-09-12
DK147584A (da) 1984-09-04
SE8401190D0 (sv) 1984-03-02
BE899059A (fr) 1984-09-03

Similar Documents

Publication Publication Date Title
AU1948599A (en) Anti-inflammatory compounds
JPH06507182A (ja) Ｎ−スルホニル−２−オキソインドール誘導体、それらの製造、及びそれらが存在する薬学的組成物
EP1981873A1 (fr) Derives de sulfonamides, leur preparation et leur application en tant qu'antagonistes des recepteurs de l'orexine 2
KR920007269B1 (ko) 에틸렌디아민 모노아미드 유도체의 제조방법
EP0226223A2 (en) Benzoic acid and benzoic acid ester derivatives having anti-inflammatory and analgesic activity
KR910008202B1 (ko) 벤즈아미드 유도체의 제조방법
FR2688781A1 (fr) Imidazolines n-substituees par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
US5238962A (en) Benzamide derivatives
JPH02503670A (ja) １，２，３，４，１０，１４ｂ‐ヘキサヒドロジベンゾ〔ｃ，ｆ〕ピラジノ〔１，２‐ａ〕アゼピノ誘導体及び１０‐アザ，１０‐オキサ及び１０‐チア類似体
KR900003497B1 (ko) 퀴나졸린디온 및 피리도피리미딘디온 및 이들을 함유하는 제약 조성물
US4162257A (en) N,N-dimethyl-5-phenyl-2-furamides
EP0348564A1 (en) Orally active antiandrogens
KR800000530B1 (ko) 이소인돌 유도체의 제조방법
JP2002511451A (ja) アザシクロアルカン誘導体、その製造及び治療上の使用
JPH0655751B2 (ja) ジヒドロピリジンホスホン酸環状エステル
SK166495A3 (en) Pharmacologically effective enantiomers, preparation method threof, intermediate products of this method and use
KR100246821B1 (ko) 비스테로이드성 소염진통제인 티아펜타렌카르복실산 유도체
JPS5852995B2 (ja) フルフラ−ル誘導体の製造法
CA2058641A1 (en) Dihydropyridine amides, processes for their preparation, and their use in medicaments
JPH07121898B2 (ja) アズレン誘導体、抗脂血剤及びその製法
WO1997046520A1 (fr) Derives de 4-nitro-2-phenoxysulfonanilides
JPH02256695A (ja) アデノシン化合物の新規ｒおよびｓジアステレオマーの製造法
DE2853824A1 (de) Indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPH0798824B2 (ja) 免疫調節剤

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19940907

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee